Of the three subtypes, PPARγ, in particular,represents a potential therapeutic target for CRC and IBD chemoprevention.However, the apparent ability of PPARγ to promote differentiation andmaturation of epithelial cells has also led to studies of its potential role inthe cause of CRC. This evidence concerns the gene PPARG and colorectal carcinoma.